Local cell therapy using CCL19-expressing allogeneic mesenchymal stem cells exerts robust antitumor effects by accumulating CD103+ IL-12-producing dendritic cells and priming CD8+ T cells without involving draining lymph nodes
Background Immune checkpoint blockade is a promising anticancer therapy, whereas the presence of T cells in tumor sites is indispensable for its therapeutic efficacy. To promote the infiltration of T cells and dendritic cells (DCs) into the tumor, we previously proposed a local cell therapy using ch...
Saved in:
| Main Authors: | Yuichi Iida, Mamoru Harada |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-12-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/12/12/e009683.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Eribulin mesylate exerts antitumor effects via CD103
by: Kazumasa Oya, et al.
Published: (2023-12-01) -
Elucidating the synergistic roles of CD4+ T and dendritic cells in antitumor immunity
by: Xiubao Ren
Published: (2025-01-01) -
Piezo1 deletion enhances cross-priming of CD8+ T cells by tumor-infiltrating CD11b+ dendritic cells
by: Tyler E Miller, et al.
Published: (2025-06-01) -
Complement mediated signaling on pulmonary CD103(+) dendritic cells is critical for their migratory function in response to influenza infection.
by: Matheswaran Kandasamy, et al.
Published: (2013-01-01) -
The initial draining lymph node primes the bulk of the CD8 T cell response and influences memory T cell trafficking after a systemic viral infection.
by: Matthew R Olson, et al.
Published: (2012-01-01)